--- title: "Simulations Plus|8-K:2025 財年營收 79.1 百萬美元超過預期" type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/262233861.md" published_at: "2025-10-22T11:52:10.000Z" --- # Simulations Plus|8-K:2025 財年營收 79.1 百萬美元超過預期 營收:截至 2025 財年,公佈值為 79.1 百萬美元,市場一致預期值為 78.09 百萬美元,超過預期。 ### 財務指標總結 #### 2025 財年初步結果 - **收入**: $79.1M - **收入增長**: 13% - **軟件佔比**: 58% - **調整後的 EBITDA 利潤率**: 28% - **調整後的稀釋每股收益**: $1.03 #### 2026 財年指導 - **收入**: $79M – $82M - **收入增長**: 0 – 4% - **軟件佔比**: 57 – 62% - **調整後的 EBITDA 利潤率**: 26 – 30% - **調整後的稀釋每股收益**: $1.03 - $1.10 #### 前瞻性聲明 Simulations Plus, Inc. 預計在 2025 財年儘管面臨市場挑戰,仍能實現修訂後的指導目標。公司計劃在 2026 財年繼續推進創新,推出新產品願景,提升軟件功能,深化平台整合,並推進 AI 能力。 ### Related Stocks - [SLP.US - Simulations Plus](https://longbridge.com/zh-HK/quote/SLP.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Herald Investment Management Ltd Makes New $3.02 Million Investment in Simulations Plus, Inc. $SLP | Herald Investment Management Ltd has made a new investment of approximately $3.02 million in Simulations Plus, Inc. (NAS | [Link](https://longbridge.com/zh-HK/news/276001912.md) | | Simulations Plus AGM: Shareholders Approve All Proposals, Back Annual Say-on-Pay Votes | Simulations Plus held its annual shareholder meeting virtually, chaired by CEO Shawn O’Connor. All four proposals were a | [Link](https://longbridge.com/zh-HK/news/276005355.md) | | Simulations Plus Extends Research Collaborations with FDA and NIEHS | Simulations Plus Inc. has extended its research collaborations with the FDA and NIEHS to support federal research on new | [Link](https://longbridge.com/zh-HK/news/275486385.md) | | Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations \| SLP Stock News | Simulations Plus, Inc. has announced the extension of research collaborations with the U.S. FDA and NIEHS, focusing on c | [Link](https://longbridge.com/zh-HK/news/275377833.md) | | Dir LaVange Files To Sell 866 Of Simulations Plus Inc [SLP] | LaVange Lisa, Director of Simulations Plus Inc, filed a Form 144 with the SEC to sell 866 shares of restricted securitie | [Link](https://longbridge.com/zh-HK/news/268143477.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。